Literature DB >> 495697

Complement fragments, alveolar macrophages, and alveolitis.

P M Henson, K McCarthy, G L Larsen, R O Webster, P C Giclas, R B Dreisin, T E King, J O Shaw.   

Abstract

Mechanisms of neutrophil infiltration into the rabbit alveolus have been investigated. Complement activation in the circulation induced pulmonary vascular margination but not a significant level of alveolar infiltration. Instillation of C5 fragments into the airways, however, attracted neutrophils into the alveolar airspaces. The anaphylatoxin-inactive fragment of C5, C5a des Arg, was found to be much more active in this regard than C5a. Furthermore, these fragments were shown to induce the production of a neutrophil-directed chemoctactic factor from pulmonary macrophages, raising the question of whether the C5a des Arg was acting directly to attract neutrophils or indirectly via the macrophage. To substantiate a possible role for C5 and C5 fragments in alveolitis, active C5 was demonstrated in lavage fluids, and macrophage-derived C5 cleaving enzymes have been described. Finally, a route of neutrophil infiltration via migration through the alveolar capillary wall into the interstitium is proposed, and subsequent penetration of the alveolar epithelium out into the airspace. (Am J Pathol 97:93--110, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495697      PMCID: PMC2042383     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.

Authors:  P M Henson; B Zanolari; N A Schwartzman; S R Hong
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 3.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

4.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Acute inflammatory pulmonary reactions induced by chemotactic factors.

Authors:  U Desai; D L Kreutzer; H Showell; C V Arroyave; P A Ward
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

6.  In vitro activation of complement by isolated human heart subcellular membranes.

Authors:  P C Giclas; R N Pinckard; M S Olson
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

7.  Immune-complex disease in guinea pig lungs. I. Elicitation by aerosol challenge, suppression with cobra venom factor, and passive transfer with serum.

Authors:  A K Roska; J C Garancis; V L Moore; P Abramoff
Journal:  Clin Immunol Immunopathol       Date:  1977-09

8.  The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels.

Authors:  R Anderson; A Glover; A R Rabson
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

9.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

10.  Selective neutrophil desensitization to chemotactic factors.

Authors:  J T O'Flaherty; D L Kreutzer; H J Showell; G Vitkauskas; E L Becker; P A Ward
Journal:  J Cell Biol       Date:  1979-03       Impact factor: 10.539

View more
  28 in total

1.  Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.

Authors:  B J Czermak; A B Lentsch; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Generation of C5a by phagocytic cells.

Authors:  Markus Huber-Lang; Ellen M Younkin; J Vidya Sarma; Niels Riedemann; Stephanie R McGuire; Kristina T Lu; Robin Kunkel; John G Younger; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.

Authors:  Norman F Russkamp; Robert Ruemmler; Julian Roewe; Bethany B Moore; Peter A Ward; Markus Bosmann
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

5.  In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

Authors:  T Hoffmann; E C Böttger; H P Baum; M Messner; U Hadding; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 6.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

7.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships.

Authors:  B O Meyrick; K L Brigham
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

9.  Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.

Authors:  G Camussi; I Pawlowski; C Tetta; C Roffinello; M Alberton; J Brentjens; G Andres
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

10.  [Blood destruction in pulmonary alveoli: signs of vitality and determination of survival time].

Authors:  M Oehmichen
Journal:  Z Rechtsmed       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.